This article is more than 5 years old. Information may no longer be current.

OMNIlife science names new CEO

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

OMNIlife science has announced that Richard D. Randall was appointed the company’s new chief executive officer. The appointment sees Randall replace former chief executive officer George B. Cipolletti, co-founder of the company, who will claim the role of chief technology officer for OMNIlife science.

Randall most recently served as CEO of Medical Compression Systems and has served in similar capacities for Avantis Medical and TranS1. He has more than 25 years of chief executive experience in emergent medical device firms.

“I am thrilled to be able to transition my CEO responsibilities to Rick and am confident that he is the right choice at this critical time to continue our efforts in creating products and technologies that deliver the best possible outcomes for patients. The OMNI family and our board of directors have expressed their complete support for Rick and his ability to lead OMNI into a bright future,” Cipolletti stated in a company press release.